Minerva Advisors LLC Raises Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Key Points

• Minerva Advisors LLC increased its holdings in Utah Medical Products, raising its position by 10.9%, making the stock its 8th largest holding with a valuation of $4.87 million.
• Utah Medical Products recently announced a quarterly dividend of $0.305 per share, representing a yield of 2.2%, payable on October 2nd.
• The company's stock has shown significant fluctuation, with a 12-month low of $51.26 and a high of $71.96, currently trading around $55.60.

Minerva Advisors LLC lifted its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 10.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 86,902 shares of the medical instruments supplier's stock after acquiring an additional 8,513 shares during the period. Utah Medical Products accounts for approximately 3.1% of Minerva Advisors LLC's investment portfolio, making the stock its 8th biggest holding. Minerva Advisors LLC owned about 2.65% of Utah Medical Products worth $4,870,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Bessemer Group Inc. acquired a new position in shares of Utah Medical Products during the fourth quarter valued at approximately $31,000. Tower Research Capital LLC TRC grew its position in Utah Medical Products by 172.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock valued at $32,000 after acquiring an additional 328 shares in the last quarter. Deutsche Bank AG purchased a new position in Utah Medical Products in the 4th quarter valued at approximately $43,000. Golden State Wealth Management LLC increased its holdings in Utah Medical Products by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock worth $56,000 after purchasing an additional 500 shares during the period. Finally, New Age Alpha Advisors LLC purchased a new position in Utah Medical Products in the fourth quarter worth approximately $101,000. Hedge funds and other institutional investors own 69.60% of the company's stock.

Utah Medical Products Stock Performance

NASDAQ UTMD traded up $1.33 during trading hours on Monday, hitting $56.28. The company had a trading volume of 6,489 shares, compared to its average volume of 18,422. The company has a market cap of $182.78 million, a PE ratio of 15.06 and a beta of 0.31. Utah Medical Products, Inc. has a 1-year low of $51.26 and a 1-year high of $69.30. The business has a 50 day moving average of $56.15 and a 200-day moving average of $56.71.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%. The company had revenue of $9.95 million for the quarter.

Utah Medical Products Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Wednesday, September 17th will be paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 2.2%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's payout ratio is currently 32.62%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.